NasdaqCM - Delayed Quote USD

Bellevue Life Sciences Acquisition Corp. (BLAC)

Compare
11.40
+0.06
+(0.53%)
At close: January 3 at 4:00:00 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
36,627.73
1,225.85
705.09
322.75
Total Liabilities Net Minority Interest
4,108.27
1,263.36
707.21
321.56
Total Equity Gross Minority Interest
32,519.46
-37.51
-2.12
1.19
Total Capitalization
32,519.46
-37.51
-2.12
1.19
Common Stock Equity
32,519.46
-37.51
-2.12
1.19
Net Tangible Assets
32,519.46
-37.51
-2.12
1.19
Working Capital
-2,015.65
-1,138.86
-702.45
-258.91
Invested Capital
32,519.46
1,162.49
397.88
301.19
Tangible Book Value
32,519.46
-37.51
-2.12
1.19
Total Debt
--
1,200.00
400.00
300.00
Net Debt
--
1,075.50
395.24
237.35
Share Issued
5,622.95
9,055.00
9,055.00
9,055.00
Ordinary Shares Number
5,622.95
9,055.00
9,055.00
9,055.00
12/31/2020 - 3/21/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers